• Sulfo-NHS-Biotin for CADASIL Assay Design

  2026-09-29

  Learn how Sulfo-NHS-Biotin can translate CADASIL vascular pathology into compartment-specific protein assays. This guide connects amine-reactive surface labeling with the NOTCH3 R545C model while distinguishing established evidence from proposed workflows.

• Phytol, RXR Signaling, and Translational Assay Design

  2026-09-29

  Phytol is more than a natural-product RXR probe: its isomeric composition, solvent behavior, metabolism, and GABAergic activity can materially shape translational interpretation. This thought-leadership guide connects retinoid X receptor biology with disciplined assay design and a materials-inspired framework for controlling experimental context.

• BAY-826 Workflow for Retinal Signaling Research

  2026-09-28

  BAY-826 enables concentration-controlled chemical perturbation of retinal neurovascular signaling, complementing co-culture, hypoxia, and PEDF assays. This workflow separates compound activity from solvent toxicity and uses orthogonal Tie-2/PI3K/Akt, viability, and secreted-factor readouts for more interpretable results.

• Mavorixafor Hydrochloride in Cell Assays

  2026-09-28

  A practical guide to using Mavorixafor hydrochloride (SKU A3174) in CXCR4-focused viability and proliferation experiments. It covers assay controls, formulation limits, data interpretation, and evidence-aware product selection without inventing unsupported dose or timing parameters.

• OsCPK4–OsCNGC7 Feedback in Rice Salt Tolerance

  2026-09-27

  The study identifies a phosphorylation-centered module in which OsCPK4 boosts OsCNGC7 channel activity and stability to promote salt-triggered Ca2+ influx in rice. Its time-dependent regulation offers a mechanism for initiating an early stress response while later reducing signaling to support growth recovery.

• EGCG Analogs Target Extracellular and Intracellular S. aureu

  2026-09-26

  Grosso and colleagues report that two structurally modified EGCG analogs, MCC-1 and MCC-2, improved biochemical properties while retaining or enhancing antistaphylococcal activity. In vitro findings indicate activity against extracellular Staphylococcus aureus, β-lactam potentiation against MRSA, and enhanced macrophage- and antibiotic-mediated clearance of intracellular bacteria—effects not observed with the parent EGCG in the intracellular experiments.

• Stiripentol for LDH-Linked Immunometabolism

  2026-09-25

  Use Stiripentol as a chemical probe to test whether LDH-dependent metabolic flux contributes to lactate-associated immune and epigenetic changes. This workflow pairs compound exposure with lactate, pyruvate, histone-lactylation, and immune-function readouts—while distinguishing a promising cancer-research question from an established result.

• Energy Stress, AMPK, and Ferroptosis in Proteinopathies

  2026-09-25

  This study tests whether energy stress can activate an AMPK–ACC1 defense against ferroptosis across neuronal proteinopathy models. Its cell, worm, and mouse findings connect AMPK-associated signaling with reduced lipid peroxidation and improved disease-related outcomes, while leaving important questions about pathway specificity and translation unresolved.

• MK0787 Antibacterial Activity Across Resistant Isolates

  2026-09-24

  A 1982 comparative study tested N-formimidoyl thienamycin (MK0787) against diverse clinical isolates, including ampicillin-resistant Enterobacteriaceae, and compared its in vitro activity with several newer β-lactams. Its strongest comparative advantage was against Pseudomonas aeruginosa and Acinetobacter spp.; the results also showed why activity should be interpreted by organism group and separated from bactericidal effect.

• DrPISA Extends Thermal Proteomics to Aggregated Proteomes

  2026-09-24

  DrPISA combines reverse PISA analysis with a deep eutectic solvent (DES) to improve recovery and measurement of heat-aggregated proteins, a fraction often missed by soluble-protein assays. In the reported study, DES-48 enhanced protein identification and peptide digestion, while the workflow detected thermal responses and candidate drug-interacting proteins that conventional PISA could overlook.

• PF-04971729: SGLT2 Research Workflows

  2026-09-23

  Use Ertugliflozin to study renal glucose reabsorption while separating target engagement from downstream cardiovascular effects. A mouse ischemia/reperfusion study shows why matched SGLT2 inhibition does not guarantee matched cardiac protection—and how to build that distinction into your experiments.

• S-Adenosylhomocysteine: Mechanism & Workflow

  2026-09-23

  S-Adenosylhomocysteine (SAH) is the product of SAM-dependent methyltransferase activity and a feedback inhibitor that helps determine cellular methylation potential. The strongest product-specific benchmark is growth inhibition at 25 μM in cystathionine β-synthase-deficient yeast, whereas the cited neural study supports an ionizing-radiation pathway but does not directly test SAH.

• From SOCS3 Biology to IL-7 mRNA Translation

  2026-09-22

  A translational perspective on how SOCS3-centered neuroglial biology in ocular angiogenesis can inform disciplined, hypothesis-driven use of EZ Cap™ Mouse IL-7 mRNA (m1Ψ, HA tag) in mouse research systems.

• Multimodal iPSC Platform for Cystic Fibrosis Drug Testing

  2026-09-22

  Berical and colleagues developed a human iPSC-derived airway platform that connects CFTR genotype with functional airway phenotypes and pharmacological response. By combining forskolin-induced swelling in three-dimensional spheroids with testing in polarized mucociliary cultures, the study provides a practical framework for evaluating therapies, including those aimed at rare CFTR variants.

• Norovirus Co-opts NINJ1 for Selective Secretion

  2026-09-21

  Song et al. show that murine norovirus repurposes the membrane-rupture factor NINJ1 to release the viral protein NS1, while caspase-3 cleavage enables this unconventional secretion pathway. The study combines CRISPR screening, infection models, imaging, protein-interaction analysis, mutagenesis, and in vivo perturbation to connect selective viral protein release with intestinal infection.

8089 records 1/540 page Next 12345 下5页 Last page